Joseph A Hippensteel

Years Active: 2019-2022
Publications (10 Years): 5

University of Colorado

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Colorado Jul 01 2019

United States

Instructor :: Division of Pulmonary Sciences and Critical Care Medicine

University of Colorado Jul 01 2015 - Jun 30 2019

United States

Fellow :: Department of Medicine

University of California San Francisco Jun 21 2012 - Jun 30 2015

United States

Resident :: Department of Medicine

Publications

Noah Siddiqui, Kaori Oshima, Joseph A Hippensteel
Proteoglycans and glycosaminoglycans in central nervous system injury. American journal of physiology. Cell physiology 323 (1) (2022)
Joseph A Hippensteel, Wells B LaRiviere, James F Colbert, Christophe J Langouët-Astrié, Eric P Schmidt
Heparin as a therapy for COVID-19: current evidence and future possibilities. American journal of physiology. Lung cellular and molecular physiology 319 (2) (2020)
Joseph A Hippensteel, Ellen L Burnham, Sarah E Jolley
Prevalence of venous thromboembolism in critically ill patients with COVID-19. British journal of haematology 190 (3) (2020)
Jakub M Kwiecinski, Heidi A Crosby, Claire Valotteau, Joseph A Hippensteel, Manasa K Nayak, Anil K Chauhan, Eric P Schmidt, Yves F Dufrêne, Alexander R Horswill
Staphylococcus aureus adhesion in endovascular infections is controlled by the ArlRS-MgrA signaling cascade. PLoS pathogens 15 (5) (2019)
Xing Zhang, Xiaorui Han, Ke Xia, Yongmei Xu, Yimu Yang, Kaori Oshima, Sarah M Haeger, Mario J Perez, Sarah A McMurtry, Joseph A Hippensteel, Joshay A Ford, Paco S Herson, Jian Liu, Eric P Schmidt, Robert J Linhardt
Circulating heparin oligosaccharides rapidly target the hippocampus in sepsis, potentially impacting cognitive functions. Proceedings of the National Academy of Sciences of the United States of America 116 (19) (2019)

Joseph A Hippensteel.css-eqlu8i{font-size:small;padding-left:4px;}